Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer.

Tryggvadottir H, Ygland Rödström M, Markkula A, Kenéz X, Isaksson K, Borgquist S, Jernström H.

Cancer Causes Control. 2019 Nov;30(11):1157-1170. doi: 10.1007/s10552-019-01227-6. Epub 2019 Sep 12.

PMID:
31515643
2.

Vitamin D receptor expression in invasive breast tumors and breast cancer survival.

Huss L, Butt ST, Borgquist S, Elebro K, Sandsveden M, Rosendahl A, Manjer J.

Breast Cancer Res. 2019 Jul 29;21(1):84. doi: 10.1186/s13058-019-1169-1.

3.

RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.

Harborg S, Cronin-Fenton DP, Borgquist S.

Breast Cancer Res Treat. 2019 Oct;177(3):771-772. doi: 10.1007/s10549-019-05337-2. Epub 2019 Jul 4. No abstract available.

PMID:
31270762
4.

Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II.

Lucht SA, Eliassen AH, Bertrand KA, Ahern TP, Borgquist S, Rosner B, Hankinson SE, Tamimi RM.

Cancer Causes Control. 2019 Sep;30(9):943-953. doi: 10.1007/s10552-019-01201-2. Epub 2019 Jul 1.

PMID:
31264139
5.

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration.

Leung SCY, Nielsen TO, Zabaglo LA, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Ehinger A, Fineberg S, Focke CM, Gao D, Gown AM, Gutierrez C, Hugh JC, Kos Z, Laenkholm AV, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Sugie T, van der Vegt B, Viale G, Hayes DF, McShane LM, Dowsett M; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group (BIG-NABCG).

Histopathology. 2019 Aug;75(2):225-235. doi: 10.1111/his.13880. Epub 2019 Jul 8.

PMID:
31017314
6.

Postmenopausal breast cancer and occupational exposure to chemicals.

Videnros C, Selander J, Wiebert P, Albin M, Plato N, Borgquist S, Manjer J, Gustavsson P.

Scand J Work Environ Health. 2019 Apr 8. pii: 3822. doi: 10.5271/sjweh.3822. [Epub ahead of print]

7.

Statin use and breast cancer survival - a Swedish nationwide study.

Borgquist S, Broberg P, Tojjar J, Olsson H.

BMC Cancer. 2019 Jan 11;19(1):54. doi: 10.1186/s12885-018-5263-z.

8.

Adipocytes and Obesity-Related Conditions Jointly Promote Breast Cancer Cell Growth and Motility: Associations With CAP1 for Prognosis.

Rosendahl AH, Bergqvist M, Lettiero B, Kimbung S, Borgquist S.

Front Endocrinol (Lausanne). 2018 Nov 22;9:689. doi: 10.3389/fendo.2018.00689. eCollection 2018.

9.

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients.

Tryggvadottir H, Huzell L, Gustbée E, Simonsson M, Markkula A, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.

Front Oncol. 2018 Oct 12;8:428. doi: 10.3389/fonc.2018.00428. eCollection 2018.

10.

Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.

Borgquist S, Rosendahl AH, Czene K, Bhoo-Pathy N, Dorkhan M, Hall P, Brand JS.

Breast Cancer Res. 2018 Aug 9;20(1):93. doi: 10.1186/s13058-018-1026-7.

11.

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment.

Björner S, Rosendahl AH, Tryggvadottir H, Simonsson M, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H.

Front Endocrinol (Lausanne). 2018 Jun 6;9:306. doi: 10.3389/fendo.2018.00306. eCollection 2018.

12.

Statins: a role in breast cancer therapy?

Borgquist S, Bjarnadottir O, Kimbung S, Ahern TP.

J Intern Med. 2018 Oct;284(4):346-357. doi: 10.1111/joim.12806. Epub 2018 Jul 9. Review.

13.

Association of Statin Use With Overall and Cancer Survival.

Ahern TP, Borgquist S, Cronin-Fenton DP.

JAMA Oncol. 2018 Jul 1;4(7):1015-1016. doi: 10.1001/jamaoncol.2018.0733. No abstract available.

PMID:
29800042
14.

Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

Borgquist S, Hall P, Lipkus I, Garber JE.

Cancer Prev Res (Phila). 2018 May;11(5):255-264. doi: 10.1158/1940-6207.CAPR-16-0254. Epub 2018 Apr 16. Review.

15.
16.

Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study.

Andersson G, Borgquist S, Jirström K.

Int J Cancer. 2018 Jul 1;143(1):52-62. doi: 10.1002/ijc.31302. Epub 2018 Feb 21.

17.

SNPs related to vitamin D and breast cancer risk: a case-control study.

Huss L, Butt ST, Almgren P, Borgquist S, Brandt J, Försti A, Melander O, Manjer J.

Breast Cancer Res. 2018 Jan 2;20(1):1. doi: 10.1186/s13058-017-0925-3.

18.

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer.

Björner S, Rosendahl AH, Simonsson M, Markkula A, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H.

Front Endocrinol (Lausanne). 2017 Nov 28;8:332. doi: 10.3389/fendo.2017.00332. eCollection 2017.

19.

Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study.

Orho-Melander M, Hindy G, Borgquist S, Schulz CA, Manjer J, Melander O, Stocks T.

Int J Epidemiol. 2018 Apr 1;47(2):495-505. doi: 10.1093/ije/dyx237.

PMID:
29165714
20.

Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study.

Brandt J, Borgquist S, Almgren P, Försti A, Huss L, Melander O, Manjer J.

Int J Cancer. 2018 Apr 1;142(7):1309-1321. doi: 10.1002/ijc.31156. Epub 2017 Nov 29.

21.

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.

Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee IM, Kaaks R, Campa D.

Int J Cancer. 2018 Mar 15;142(6):1182-1188. doi: 10.1002/ijc.31145. Epub 2017 Nov 17.

22.

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.

Elebro K, Bendahl PO, Jernström H, Borgquist S.

Breast Cancer Res Treat. 2017 Oct;165(3):645-657. doi: 10.1007/s10549-017-4343-0. Epub 2017 Jun 22.

23.

Female white-collar workers remain at higher risk of breast cancer after adjustments for individual risk factors related to reproduction and lifestyle.

Kullberg C, Selander J, Albin M, Borgquist S, Manjer J, Gustavsson P.

Occup Environ Med. 2017 Sep;74(9):652-658. doi: 10.1136/oemed-2016-104043. Epub 2017 Apr 29.

24.

Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.

Kimbung S, Chang CY, Bendahl PO, Dubois L, Thompson JW, McDonnell DP, Borgquist S.

Endocr Relat Cancer. 2017 Jul;24(7):339-349. doi: 10.1530/ERC-16-0533. Epub 2017 Apr 25.

25.

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

Borgquist S, Giobbie-Hurder A, Ahern TP, Garber JE, Colleoni M, Láng I, Debled M, Ejlertsen B, von Moos R, Smith I, Coates AS, Goldhirsch A, Rabaglio M, Price KN, Gelber RD, Regan MM, Thürlimann B.

J Clin Oncol. 2017 Apr 10;35(11):1179-1188. doi: 10.1200/JCO.2016.70.3116. Epub 2017 Feb 13.

PMID:
28380313
26.

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA).

Gabrielson M, Eriksson M, Hammarström M, Borgquist S, Leifland K, Czene K, Hall P.

Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g. doi: 10.1093/ije/dyw357. No abstract available.

27.

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups.

Björner S, Rosendahl AH, Simonsson M, Markkula A, Jirström K, Borgquist S, Rose C, Ingvar C, Jernström H.

Oncotarget. 2017 Feb 7;8(6):9093-9107. doi: 10.18632/oncotarget.14082.

28.

Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.

Andersson G, Wennersten C, Borgquist S, Jirström K.

Biol Sex Differ. 2016 Dec 9;7:66. eCollection 2016.

29.

Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort.

Fortner RT, Hüsing A, Kühn T, Konar M, Overvad K, Tjønneland A, Hansen L, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Agnoli C, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Gram IT, Gavrilyuk O, Quirós JR, Maria Huerta J, Ardanaz E, Larrañaga N, Lujan-Barroso L, Sánchez-Cantalejo E, Butt ST, Borgquist S, Idahl A, Lundin E, Khaw KT, Allen NE, Rinaldi S, Dossus L, Gunter M, Merritt MA, Tzoulaki I, Riboli E, Kaaks R.

Int J Cancer. 2017 Mar 15;140(6):1317-1323. doi: 10.1002/ijc.30560.

30.

Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.

Perez-Cornago A, Appleby PN, Tipper S, Key TJ, Allen NE, Nieters A, Vermeulen R, Roulland S, Casabonne D, Kaaks R, Fortner RT, Boeing H, Trichopoulou A, La Vecchia C, Klinaki E, Hansen L, Tjønneland A, Bonnet F, Fagherazzi G, Boutron-Ruault MC, Pala V, Masala G, Sacerdote C, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Dorronsoro M, Quirós JR, Barricarte A, Gavrila D, Agudo A, Borgquist S, Rosendahl AH, Melin B, Wareham N, Khaw KT, Gunter M, Riboli E, Vineis P, Travis RC.

Int J Cancer. 2017 Mar 1;140(5):1111-1118. doi: 10.1002/ijc.30528. Epub 2016 Dec 27.

31.

High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.

Elebro K, Borgquist S, Rosendahl AH, Markkula A, Simonsson M, Jirström K, Rose C, Ingvar C, Jernström H.

Clin Cancer Res. 2017 Feb 1;23(3):766-777. doi: 10.1158/1078-0432.CCR-16-1095. Epub 2016 Nov 3.

32.

Thyroid function and survival following breast cancer.

Brandt J, Borgquist S, Almquist M, Manjer J.

Br J Surg. 2016 Nov;103(12):1649-1657. doi: 10.1002/bjs.10284. Epub 2016 Sep 6.

PMID:
27599301
33.

The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.

Simonsson M, Björner S, Markkula A, Nodin B, Jirström K, Rose C, Borgquist S, Ingvar C, Jernström H.

Int J Cancer. 2017 Jan 1;140(1):163-175. doi: 10.1002/ijc.30432. Epub 2016 Sep 28.

34.

Fiber intake modulates the association of alcohol intake with breast cancer.

Romieu I, Ferrari P, Chajès V, de Batlle J, Biessy C, Scoccianti C, Dossus L, Christine Boutron M, Bastide N, Overvad K, Olsen A, Tjønneland A, Kaaks R, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Gils CH, Peeters PH, Lund E, Skeie G, Weiderpass E, Ramón Quirós J, Chirlaque MD, Ardanaz E, Sánchez MJ, Duell EJ, Amiano Etxezarreta P, Borgquist S, Hallmans G, Johansson I, Maria Nilsson L, Khaw KT, Wareham N, Key TJ, Travis RC, Murphy N, Wark PA, Riboli E.

Int J Cancer. 2017 Jan 15;140(2):316-321. doi: 10.1002/ijc.30415.

35.

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer.

Kimbung S, Lettiero B, Feldt M, Bosch A, Borgquist S.

Oncotarget. 2016 Sep 13;7(37):59640-59651. doi: 10.18632/oncotarget.10746.

36.

Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort.

Dias JA, Fredrikson GN, Ericson U, Gullberg B, Hedblad B, Engström G, Borgquist S, Nilsson J, Wirfält E.

PLoS One. 2016 Jul 8;11(7):e0158959. doi: 10.1371/journal.pone.0158959. eCollection 2016.

37.

Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control study.

Shirazi L, Almquist M, Borgquist S, Malm J, Manjer J.

Breast. 2016 Aug;28:184-90. doi: 10.1016/j.breast.2016.06.002. Epub 2016 Jun 18.

38.

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration.

Leung SCY, Nielsen TO, Zabaglo L, Arun I, Badve SS, Bane AL, Bartlett JMS, Borgquist S, Chang MC, Dodson A, Enos RA, Fineberg S, Focke CM, Gao D, Gown AM, Grabau D, Gutierrez C, Hugh JC, Kos Z, Lænkholm AV, Lin MG, Mastropasqua MG, Moriya T, Nofech-Mozes S, Osborne CK, Penault-Llorca FM, Piper T, Sakatani T, Salgado R, Starczynski J, Viale G, Hayes DF, McShane LM, Dowsett M.

NPJ Breast Cancer. 2016 May 18;2:16014. doi: 10.1038/npjbcancer.2016.14. eCollection 2016.

39.

Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists' qualitative classification.

Sartor H, Lång K, Rosso A, Borgquist S, Zackrisson S, Timberg P.

Eur Radiol. 2016 Dec;26(12):4354-4360. Epub 2016 Mar 24.

40.

Apolipoproteins, lipids and risk of cancer.

Borgquist S, Butt T, Almgren P, Shiffman D, Stocks T, Orho-Melander M, Manjer J, Melander O.

Int J Cancer. 2016 Jun 1;138(11):2648-56. doi: 10.1002/ijc.30013. Epub 2016 Feb 8.

41.

Statin Use and Breast Cancer Risk in the Nurses' Health Study.

Borgquist S, Tamimi RM, Chen WY, Garber JE, Eliassen AH, Ahern TP.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):201-6. doi: 10.1158/1055-9965.EPI-15-0654.

42.

Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Kyrø C, Zamora-Ros R, Scalbert A, Tjønneland A, Dossus L, Johansen C, Bidstrup PE, Weiderpass E, Christensen J, Ward H, Aune D, Riboli E, His M, Clavel-Chapelon F, Baglietto L, Katzke V, Kühn T, Boeing H, Floegel A, Overvad K, Lasheras C, Travier N, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Khaw KT, Wareham N, Perez-Cornago A, Trichopoulou A, Lagiou P, Vasilopoulou E, Masala G, Grioni S, Berrino F, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, van Gils C, Borgquist S, Butt S, Zeleniuch-Jacquotte A, Sund M, Hjartåker A, Skeie G, Olsen A, Romieu I.

Breast Cancer Res Treat. 2015 Nov;154(2):389-401. doi: 10.1007/s10549-015-3595-9. Epub 2015 Nov 3.

43.

ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICS.

Förnvik D, Lång K, Andersson I, Dustler M, Borgquist S, Timberg P.

Radiat Prot Dosimetry. 2016 Jun;169(1-4):151-7. doi: 10.1093/rpd/ncv417. Epub 2015 Sep 25.

PMID:
26410768
44.

Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.

Melander O, Orho-Melander M, Manjer J, Svensson T, Almgren P, Nilsson PM, Engström G, Hedblad B, Borgquist S, Hartmann O, Struck J, Bergmann A, Belting M.

J Clin Oncol. 2015 Aug 20;33(24):2632-8. doi: 10.1200/JCO.2014.59.7682. Epub 2015 Jul 13.

PMID:
26169618
45.

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.

BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015.

46.

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

Borgquist S, Zhou W, Jirström K, Amini RM, Sollie T, Sørlie T, Blomqvist C, Butt S, Wärnberg F.

BMC Cancer. 2015 Jun 11;15:468. doi: 10.1186/s12885-015-1479-3.

47.

Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.

Brandt J, Borgquist S, Manjer J.

Cancer Causes Control. 2015 Aug;26(8):1093-104. doi: 10.1007/s10552-015-0602-8. Epub 2015 Jun 2.

PMID:
26033776
48.

Effects of statin use on volumetric mammographic density: results from the KARMA study.

Skarping I, Brand JS, Hall P, Borgquist S.

BMC Cancer. 2015 May 28;15:435. doi: 10.1186/s12885-015-1457-9.

49.

Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.

Feldt M, Bjarnadottir O, Kimbung S, Jirström K, Bendahl PO, Veerla S, Grabau D, Hedenfalk I, Borgquist S.

J Transl Med. 2015 Apr 29;13:133. doi: 10.1186/s12967-015-0486-0.

50.

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort.

Elebro K, Borgquist S, Simonsson M, Markkula A, Jirström K, Ingvar C, Rose C, Jernström H.

Clin Cancer Res. 2015 Aug 15;21(16):3640-50. doi: 10.1158/1078-0432.CCR-14-2564. Epub 2015 Apr 22.

Supplemental Content

Loading ...
Support Center